Form 8-K - Current report:
SEC Accession No. 0001564590-19-017212
Filing Date
2019-05-08
Accepted
2019-05-08 16:15:27
Documents
3
Period of Report
2019-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arav-8k_20190508.htm 8-K 30218
2 EX-99.1 arav-ex991_6.htm EX-99.1 122739
3 GRAPHIC ga0hbf3e5520000001.jpg GRAPHIC 2961
  Complete submission text file 0001564590-19-017212.txt   158421
Mailing Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010
Business Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 19806780
SIC: 2834 Pharmaceutical Preparations